
<!DOCTYPE html>
<html lang="en-US" class=" js">
<head>
<!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-1CD9F90731"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-1CD9F90731');
</script>


<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8495225890363177"
     crossorigin="anonymous"></script>
     
 

<link rel="stylesheet" href="https://education-academia.github.io/css/bootstrap.min.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/style.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/custom.css">
<link rel="icon" href="https://education-academia.github.io/images/favicon.png" type="image/x-icon">
<link href="https://cdn.rawgit.com/westonganger/bootstrap-directional-buttons/master/dist/bootstrap-directional-buttons.css" rel="stylesheet" type="text/css">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Which Country has launched a new Alzheimers drug treatment?
</title>
<meta name="description" content="The US Food and Drug Administration (FDA) has approved lecanemab, the second-ever treatment for Alzheimers disease that is intended to tackle the root of the condition and the slow cognitive decline that results.Lecanemab works by removing a sticky protein from the brain that is believed to cause Alzheimers disease to advance. Its very exciting because this is the first treatment in our history that shows an unequivocal slowing of decline in Alzheimers disease, says Dr. van Dyck.Dementia Care – Netherlands The Netherlands has proven itself about as innovative as they come in terms of dementia care across the globe. In fact, one of the most popular and widely known dementia care communities is located outside of Amsterdam.The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company that also developed the first symptomatic treatment for Alzheimers 25 years ago.Donepezil (Aricept®): approved to treat all stages of Alzheimers disease. Rivastigmine (Exelon®): approved for mild-to-moderate Alzheimers as well as mild-to-moderate dementia associated with Parkinsons disease. Galantamine (Razadyne®): approved for mild-to-moderate stages of Alzheimers disease.">
<meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1'>
<meta name="keywords" content=" What is the newest drug for Alzheimers?, What country has the best Alzheimers treatment?, Who made the new Alzheimers drug?, What is the treatment drug for Alzheimers? ">
</head>
<body data-rsssl="1" class="page-template-default custom-background custom-background-white custom-font-enabled single-author" style="padding: 0px 0px 154px;">
<div id="page" class="site" style="height: auto !important;">
<header id="masthead" class="site-header" role="banner">
<div class="io-title-description">
<a href="https://education-academia.github.io" title="Change your future" rel="home">EDUCATION FOR ALL
</a>
<br>
<a class="site-description">The MCQ hub
</a>
</div>
<nav id="site-navigation" class="themonic-nav" role="navigation">
<a class="assistive-text" href="#main" title="Skip to content">Skip to content
</a>
<ul id="menu-top" class="nav-menu">
<li id="menu-item-695195" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-695195">
<a href="https://education-academia.github.io/">Home
</a>
</li>
</ul>
<select class="selectnav" id="selectnav1">
<option value="">Menu
</option>
<option value="https://education-academia.github.io">HOME
</option>
</select>
</nav>
<!-- #site-navigation -->
<div class="clear">
</div>
</header>
<!-- #masthead -->
<div id="main" class="wrapper">
<div id="primary" class="site-content">
<div id="content" role="main">
<article id="post-1014223" class="post-1014223 page type-page status-publish hentry">
<header class="entry-header">
<h1 class="entry-title"> CURRENT AFFAIRS
</h1>
</header>
<div class="entry-content">
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2020/icici-bank-and-which-bank-signed-mou-to-support-small--medium-sized-enterprises-and-start-ups.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2020/which-state-is-to-replace-yash-bharti-awards-with-state-cultural-award.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<div style="text-align:center">
<h2>2020 
</h2>
<h3>
</h3>
<p style="text-align: center;">
<a href="https://drive.google.com/drive/folders/1JxfIMvv4AW-4Jl_pC6NHChgZJETuMZiE?usp=share_link" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>DOWNLOAD FREE PDF BOOK (USEFUL FOR TEACHERS/INSTRUCTORS/COACHING INSTITUTES)
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/download.gif">
</span>
</a>
</p>
</div>
<strong> Which Country has launched a new Alzheimer’s drug treatment? 
</strong>
<p>(A) USA 
</p>
<p>(B) South Korea 
</p>
<p>(C) India 
</p>
<p>(D) ** China 
</p>
<p>
<div style ="text-align:center">
<h3>EXPLANATIONS BELOW
</h3>
</div>
<p>
<strong>Concept note-1:
</strong>-The US Food and Drug Administration (FDA) has approved lecanemab, the second-ever treatment for Alzheimer’s disease that is intended to tackle the root of the condition and the slow cognitive decline that results.
</p>
<p>
<strong>Concept note-2:
</strong>-Lecanemab works by removing a sticky protein from the brain that is believed to cause Alzheimer’s disease to advance. “It’s very exciting because this is the first treatment in our history that shows an unequivocal slowing of decline in Alzheimer’s disease, ” says Dr. van Dyck.
</p>
<p>
<strong>Concept note-3:
</strong>-Dementia Care – Netherlands The Netherlands has proven itself about as innovative as they come in terms of dementia care across the globe. In fact, one of the most popular and widely known dementia care communities is located outside of Amsterdam.
</p>
<p>
<strong>Concept note-4:
</strong>-The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company that also developed the first symptomatic treatment for Alzheimer’s 25 years ago.
</p>
<p>
<strong>Concept note-5:
</strong>-Donepezil (Aricept®): approved to treat all stages of Alzheimer’s disease. Rivastigmine (Exelon®): approved for mild-to-moderate Alzheimer’s as well as mild-to-moderate dementia associated with Parkinson’s disease. Galantamine (Razadyne®): approved for mild-to-moderate stages of Alzheimer’s disease. 
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2020/icici-bank-and-which-bank-signed-mou-to-support-small--medium-sized-enterprises-and-start-ups.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2020/which-state-is-to-replace-yash-bharti-awards-with-state-cultural-award.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<p style="text-align: center;">
<a href="https://play.google.com/store/books/author?id=Narayan+Changder" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>BUY E-BOOK WITH ANSWER KEYS GIVEN AT THE END OF EVERY PAGE
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/buynow.webp">
</span>
</a>
</p>
</div>
<!-- .entry-content -->
<footer class="entry-meta">
</footer>
<!-- .entry-meta -->
</article>
<!-- #post -->
<div id="comments" class="comments-area">
</div>
<!-- #comments .comments-area -->
</div>
<!-- #content -->
</div>
<!-- #primary -->
<div id="secondary" class="widget-area" role="complementary">
<aside id="search-3" class="widget widget_search">
<ul>
<li>
<a href="https://education-academia.github.io/current-affairs/2016/1.html">
<strong>CURRENT AFFAIRS-2016
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2017/1.html">
<strong>CURRENT AFFAIRS-2017 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2018/1.html">
<strong>CURRENT AFFAIRS-2018 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2019/1.html">
<strong>CURRENT AFFAIRS-2019 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2020/1.html">
<strong>CURRENT AFFAIRS-2020 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2021/1.html">
<strong>CURRENT AFFAIRS-2021 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2022/1.html">
<strong>CURRENT AFFAIRS-2022 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2023/1.html">
<strong>CURRENT AFFAIRS-2023 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2024/1.html">
<strong>CURRENT AFFAIRS-2024 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2025/1.html">
<strong>CURRENT AFFAIRS-2025
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2026/1.html">
<strong>CURRENT AFFAIRS-2026
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2027/1.html">
<strong>CURRENT AFFAIRS-2027
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2028/1.html">
<strong>CURRENT AFFAIRS-2028 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2029/1.html">
<strong>CURRENT AFFAIRS-2029 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2030/1.html">
<strong>CURRENT AFFAIRS-2030 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/miscellaneous/1.html">
<strong>CURRENT AFFAIRS-MISCELLANEOUS 
</strong>
</a>
</li>
</ul>
</aside>
</div>
<!-- #secondary -->
</div>
<!-- #main .wrapper -->
<footer id="colophon" role="contentinfo">
<div class="site-info">
<div class="footercopy">
</div>
<div class="footercredit">
</div>
<div class="clear">
</div>
</div>
<!-- .site-info -->
</footer>
<!-- #colophon -->
<div class="site-wordpress">
</div>
<!-- .site-info -->
<div class="clear">
</div>
</div>
<!-- #page -->
<script src="https://education-academia.github.io/js/jquery.min.js">
</script>
<script src="https://education-academia.github.io/js/bootstrap.min.js">
</script>
</body>
</html>